(E)-3-(1-Benzyl-3-chlorooxalyl-2-methyl-1H-indol-4-yl)-acrylic acid methyl ester | 1026078-03-4

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: (E)-3-(1-Benzyl-3-chlorooxalyl-2-methyl-1H-indol-4-yl)-acrylic acid methyl ester
• 英文别名: methyl (E)-3-[1-benzyl-3-(2-chloro-2-oxoacetyl)-2-methylindol-4-yl]prop-2-enoate
• CAS: 1026078-03-4
• 化学式: C₂₂H₁₈ClNO₄
• 分子量: 395.842
• InChiKey: RTYAVCLFLRBOTC-VAWYXSNFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  28
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  65.4
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (E)-3-(1-Benzyl-3-chlorooxalyl-2-methyl-1H-indol-4-yl)-acrylic acid methyl ester 在 sodium hydroxide 、 氨 作用下， 以 四氢呋喃 、 乙醇 、 二氯甲烷 为溶剂， 反应 15.5h， 生成 (E)-3-(3-Aminooxalyl-1-benzyl-2-methyl-1H-indol-4-yl)-acrylic acid
  参考文献：
  名称：

  Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A₂. 3. Indole-3-glyoxamides

  摘要：

  The preceding papers of this series detail the development of functionalized indole-3-acetamides as inhibitors of hnps-PLA(2). We describe here the extension of the structure-activity relationship to include a series of indole-3-glyoxamide derivatives. Functionalized indole-3-glyoxamides with an acidic substituent appended to the 4- or 5-position of the indole ring were prepared and tested as inhibitors of hnps-PLA(2). It was found that the indole-3-glyoxamides with a 4-oxyacetic acid substituent had optimal inhibitory activity. These inhibitors exhibited an improvement in potency over the best of the indole-3-acetamides, and LY315920 (6m) was selected for evaluation clinically as an hnps-PLA(2) inhibitor.

  DOI：

  10.1021/jm960487f
• 作为产物：
  描述：

  2-甲基吲哚啉 在 正丁基锂 、 silver(II) sulfate 、 硫酸 、 溴 、 potassium carbonate 、 2,3-二氯-5,6-二氰基-1,4-苯醌 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 二氯甲烷 为溶剂， 反应 20.0h， 生成 (E)-3-(1-Benzyl-3-chlorooxalyl-2-methyl-1H-indol-4-yl)-acrylic acid methyl ester
  参考文献：
  名称：

  Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A₂. 3. Indole-3-glyoxamides

  摘要：

  The preceding papers of this series detail the development of functionalized indole-3-acetamides as inhibitors of hnps-PLA(2). We describe here the extension of the structure-activity relationship to include a series of indole-3-glyoxamide derivatives. Functionalized indole-3-glyoxamides with an acidic substituent appended to the 4- or 5-position of the indole ring were prepared and tested as inhibitors of hnps-PLA(2). It was found that the indole-3-glyoxamides with a 4-oxyacetic acid substituent had optimal inhibitory activity. These inhibitors exhibited an improvement in potency over the best of the indole-3-acetamides, and LY315920 (6m) was selected for evaluation clinically as an hnps-PLA(2) inhibitor.

  DOI：

  10.1021/jm960487f